Clinical Overview

Non-specific intraventricular conduction delay (NSIVCD, also written IVCD) — this dataset’s “Intraventricular Block” (IVB) label — is a widened-QRS finding on the surface ECG that does not fit the specific diagnostic pattern of either left bundle branch block (LBBB) or right bundle branch block (RBBB). The AHA/ACCF/HRS 2009 standardization statement defines it as a QRS duration greater than 110 ms in adults (greater than 90 ms in children 8-16 years, greater than 80 ms in children under 8) that does not meet LBBB or RBBB criteria (Surawicz et al., Circulation, 2009). [CLINICAL REVIEW NEEDED: the adult ≥110 ms threshold is confirmed against this source, but the specific pediatric split (>90 ms for ages 8-16, >80 ms under 8) could not be independently verified.] A 2023 cohort study of dilated cardiomyopathy patients uses this identical “≥110 ms and not meeting LBBB or RBBB criteria” definition, confirming the threshold is still current (Yuan, Yang et al., BMC Cardiovascular Disorders, 2023). Despite what the acronym “IVB” and this dataset’s literal label suggest, it is not a specific named block the way CRBBB or LBBB are — it is best understood as a residual, exclusion-based category: a QRS wide enough to signal a real conduction abnormality, but with a morphology too variable or nonspecific to assign to one of the classic named patterns. The underlying SNOMED CT code this dataset maps IVB to resolves to exactly this “Non-specific intraventricular conduction delay” concept — not to a specific named bundle branch block — so this page is scoped to that nonspecific finding rather than to right bundle branch block, incomplete right bundle branch block, incomplete left bundle branch block, or the left-anterior-fascicular-territory finding this dataset labels LFBBB, each of which has (or will have) its own dedicated page.

Mechanistically, a widened QRS means ventricular depolarization is taking longer than normal to complete, but unlike LBBB or RBBB — where a single bundle branch is blocked and activation follows a predictable, stereotyped detour through the other side — NSIVCD’s delay is diffuse or variable enough that it does not reproduce either of those recognizable patterns. One proposed mechanism is that NSIVCD represents a form of electrical dyssynchrony similar to LBBB, which may in turn drive the same kind of mechanical dyssynchrony and impaired left-ventricular systolic function seen with LBBB, though this mechanical link was not directly measured in the cohort that proposed it and is not settled. [CLINICAL REVIEW NEEDED: the mechanical-dyssynchrony explanation is proposed, not directly demonstrated, in the source cited for it.]

Clinically, NSIVCD carries real prognostic weight rather than being a purely incidental finding. In a 2023 cohort of 548 patients with dilated cardiomyopathy followed for a median of 58 months, NSIVCD was an independent predictor of worse outcomes (hazard ratio 1.72), with a composite adverse-outcome rate of 49.2% versus 14.7% in patients without any intraventricular conduction delay (Yuan, Yang et al., 2023). Separately, case reports describe a widened, LBBB-like but non-classic (“atypical LBBB”) pattern that can evolve during acute myocardial injury and obscure the ECG recognition of acute coronary occlusion, which is why a new or changing wide-QRS pattern in a patient with a presentation concerning for acute coronary syndrome deserves the same urgency as a recognized bundle branch block, regardless of the exact morphology label (Nikus et al., Journal of Electrocardiology, 2022). [CLINICAL REVIEW NEEDED: this masking pattern is described in case-level reports, not large prospective cohorts, so its frequency in general practice is not established.]

NSIVCD itself produces no symptoms — it is a conduction/morphology finding on the ECG, not a rhythm disturbance a patient feels. Any symptoms present come from whatever underlying condition is producing the delay: dyspnea, fatigue, or other heart-failure symptoms if a cardiomyopathy is the cause, or symptoms referable to a dangerous reversible cause such as hyperkalemia (weakness, palpitations) or tricyclic antidepressant/sodium-channel-blocker toxicity (altered mental status, seizure, arrhythmia) if one of those is present.

Recognized causes and risk factors include diffuse or patchy myocardial disease that slows cell-to-cell conduction without following either bundle branch’s exact path — extensive prior myocardial infarction with scar, myocardial fibrosis, infiltrative cardiomyopathy such as amyloidosis, and non-ischemic or dilated cardiomyopathy — as well as left ventricular hypertrophy. Two reversible, potentially life-threatening causes must always be considered and excluded before a widened QRS is accepted as a benign nonspecific finding: hyperkalemia and tricyclic antidepressant (or other sodium-channel-blocker) poisoning, both of which can widen the QRS through a different, drug- or electrolyte-driven mechanism rather than structural conduction disease (LITFL, 2020). Ventricular pre-excitation (Wolff-Parkinson-White) has also been reported alongside this appearance in a way that can mislead rhythm diagnosis: a case report describes NSIVCD’s QRS/T morphology being misread as a P wave, causing atrial fibrillation to be mistaken for sinus rhythm (Parlavecchio et al., Journal of Electrocardiology, 2022).

Interpretation Guide

Key Features:

• Rate: not a defining feature — NSIVCD is a QRS-morphology finding superimposed on whatever rate accompanies it
• Rhythm: not a defining feature — it is described against an underlying supraventricular rhythm; a wide QRS originating from a ventricular rhythm (e.g., ventricular tachycardia, accelerated idioventricular rhythm) is a different mechanism entirely and not this finding
• P waves: within normal limits unless a coexisting atrial finding is present
• PR interval: within normal limits unless a separate, coexisting AV conduction abnormality is present
• QRS complex: the defining feature — duration greater than 110 ms in adults (greater than 90 ms for children 8-16 years, greater than 80 ms for children under 8 — pediatric split [CLINICAL REVIEW NEEDED], see Clinical Overview), with morphology that does not meet the specific criteria for LBBB (broad, monophasic R waves in I, aVL, V5-6 with absent septal q waves) or RBBB (rSR’ pattern in V1 with a wide, slurred S wave in the lateral leads) — this is a diagnosis of exclusion made after ruling out those two specific patterns
• ST segment: not a defining feature; nonspecific ST changes can accompany the underlying cause (e.g., cardiomyopathy, LVH) rather than the conduction delay itself
• T waves: not a defining feature; nonspecific T wave changes can likewise accompany the underlying cause
• QT interval: not independently diagnostic; the measured QT can lengthen somewhat simply because the QRS itself is wider, so QT prolongation should not be read as a separate finding without accounting for QRS width
• Other findings: before accepting a widened, nonspecific QRS as this benign-sounding label, rule out hyperkalemia (check serum potassium) and tricyclic antidepressant or other sodium-channel-blocker toxicity, since both can present with an identical widened, non-classic QRS and require urgent, specific treatment rather than routine monitoring

Key Leads

• No single lead defines this finding by itself — by definition, the QRS does not show the lead-specific morphology (rSR’ in V1 for RBBB; broad monophasic R with absent septal q in I, aVL, V5-6 for LBBB) that identifies a named block.
• V1 — check for the absence of the RBBB rSR’ pattern; a widened QRS without this morphology supports NSIVCD over RBBB.
• Leads I, aVL, V5-V6 — check for the absence of the broad, monophasic R wave and absent septal q wave that define LBBB; presence of that pattern instead points to LBBB, not NSIVCD.
• Whichever lead shows the widest QRS complex — used to confirm the QRS duration itself crosses the diagnostic threshold, since apparent width can vary by lead depending on the frontal-plane axis.

Differential Diagnosis

• Complete Right Bundle Branch Block (CRBBB) — a specific named block this finding is explicitly scoped away from. Distinguishing clue: a QRS ≥120 ms with an rSR’ (“M-shaped”) pattern in V1-V2 and a wide, slurred S wave in the lateral leads (I, aVL, V5-6) meets CRBBB’s defined morphology and should be labeled CRBBB rather than NSIVCD.
• Incomplete Right Bundle Branch Block (IRBBB) — a shorter-duration but morphologically classic version of the same pattern. Distinguishing clue: a QRS of roughly 100-119 ms that still shows the characteristic rSR’ pattern in V1 is IRBBB, not NSIVCD — NSIVCD requires morphology that does not reproduce this classic pattern at all, not just a shorter QRS.
• Left Front Bundle Branch Block (LFBBB) — this dataset’s label for a left-anterior-fascicular-territory conduction finding, not true complete left bundle branch block. Distinguishing clue: left axis deviation with a qR pattern in leads I and aVL, an rS pattern in II, III, and aVF, and a QRS duration that is normal or only mildly prolonged (unlike the ≥120 ms widening required for true LBBB) points to this fascicular pattern rather than NSIVCD’s nonspecific, non-fascicular widening.
• Left Ventricle Hypertrophy (LVH) — one of the recognized underlying causes of a widened, nonspecific QRS, and can coexist with or produce this finding. Distinguishing clue: voltage criteria (e.g., tall R waves in the lateral leads, deep S waves in V1-V2) and a strain pattern of ST depression with T wave inversion in the lateral leads point to LVH as the driver rather than treating the QRS widening as an isolated, unexplained conduction finding.

Treatment Brief

NSIVCD is a descriptive ECG finding, not a rhythm or condition to treat directly — the response depends on ruling out dangerous reversible causes and identifying what, if anything, is driving it.

• Before accepting a widened, nonspecific QRS as benign, check the serum potassium and consider tricyclic antidepressant or other sodium-channel-blocker exposure — both are reversible, potentially life-threatening causes of an identical-appearing widened QRS and change management immediately if found.
• Compare against a prior ECG when available; a new nonspecific widening in a previously normal tracing deserves more attention than a longstanding, stable one.
• If NSIVCD occurs in a patient with known or suspected structural heart disease or cardiomyopathy, flag it for cardiology follow-up rather than dismissing it as an incidental finding, given its independent association with worse outcomes in that population.
• If a new or evolving wide, nonspecific QRS accompanies a presentation concerning for acute coronary syndrome, notify the provider promptly — this pattern can mask the ECG recognition of acute coronary occlusion.
• Confirm lead placement and repeat the tracing if the finding is new or unexpected, since technical factors can occasionally produce a misleadingly widened complex.